mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
Bacillus anthracis is surrounded by an antiphagocytic polypeptide capsule composed of poly gamma-D-glutamic acid (gammaDPGA). gammaDPGA has been identified recently as a potential target for vaccine development. Studies of the role of gammaDPGA in disease have been hampered by the poor Ab response to this antigen and the lack of immunochemical reagents. As a consequence, neither the extent of gammaDPGA production during anthrax nor the protective activity of gammaDPGA Abs in inhalation anthrax are known. Here we report production of IgG Abs to gammaDPGA in mice following an immunization regimen using gammaDPGA in combination with agonist mAbs to CD40. mAbs were produced that are specific for gammaDPGA. Passive immunization with gammaDPGA mAbs protected >90% of mice in a pulmonary model of anthrax that was lethal in control mice (P < 0.0001). Use of gammaDPGA mAb in an antigen detection immunoassay found that the appearance of gammaDPGA in serum coincided with the emergence of bacteremia. These studies identify CD40 stimulation as a means for production of Ab and generation of mAbs against a weakly immunogenic antigen and demonstrate that the capsule is an effective target for immunoprotection and for antigen detection in the diagnosis of anthrax.
Kozel
Thomas R
TR
Department of Microbiology and Immunology, University of Nevada School of Medicine, Reno, NV 89557, USA. trkozel@med.unr.edu
Murphy
William J
WJ
Brandt
Suzanne
S
Blazar
Bruce R
BR
Lovchik
Julie A
JA
Thorkildson
Peter
P
Percival
Ann
A
Lyons
C Rick
CR
D000818:Animals; D000881:Anthrax / Q000175:diagnosis* / Q000276:immunology / Q000517:prevention & control; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000942:Antigens, Bacterial / Q000097:blood* / Q000276:immunology; D001408:Bacillus anthracis / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D051379:Mice
D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial